Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. Generex Biotechnology Corp. (GNBTQ) Message Board

Here is my Q&A with Joe on 10/15/2019 conf call (y

Message Board Public Reply | Private Reply | Keep | Replies (1)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 36566
(Total Views: 241)
Posted On: 12/03/2020 2:25:35 PM
Avatar
Posted By: tc2000chartreader
Re: rjs9787 #24104
Here is my Q&A with Joe on 10/15/2019 conf call (yes more than 1 year ago) talking about a new appraisal. I guess it never happened.
Quote:
Steve: That was many, many years ago, and that appraisal [?] was around, what... it
was 300 million? Is that still effective or do you think it's--obviously, we
think it's a lot higher than and I could see it come a lot farther along--we have
a lot more things that are underneath--Antigen at this point, especially with
the ALTuCELL that you're going to incorporate--that's going to be
incorporated into the NGIO, right?
Joe: No, ALTuCELL will be on Generex. And then obviously, ALTuCELL will
get our oral and assets for Type 2, which has been reformulated, and that we
will get back into the clinic. But first and foremost, see the FDA on what we
could utilize from all those past trials, hopefully on safety and on efficacy
_____ [00:47:04] for Type 2s instead of Type 1s.
GENEREX_10152019
Page 14 of 28
Steve: Okay. So, what kind of value are you thinking NGIO has at this point? Are
you getting another assessment done, another appraisal done that will be
released? Or do you have a value in mind with the reverse merger and the
listing?
Joe: Certainly, Generex is putting tens upon tens upon tens of millions of dollars
into Antigen. So, there's a value on the money that we've put into the
company, as well as we have looked into rekindling the appraisals on the
platforms that we had done before. As you mentioned, it was... I believe over
300 million just on breast cancer. It is a platform technology with the IIT
platform.
So, right now, we've reached out to appraisal companies that just do pharma,
and that's going to help us establish pricing for when the company is public
come towards the end of November. So, that's a play of our initiatives, get
something like that done to establish what the value of Antigen is.
And then there are set parameters, partnerships with Big Pharma, where you
are in the clinic, that all is part of how you value especially immunotherapy
assets.



(2)
(0)




Generex Biotechnology Corp. (GNBTQ) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  


Disclaimer: Of course, all of this is my opinion and you should not make any investment decisions based on my opinion. I have not received any non-public information.




Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us